Rapid Micro Biosystems (NASDAQ:RPID) Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of Rapid Micro Biosystems (NASDAQ:RPID) from a hold rating to a sell rating in a report issued on Sunday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Rapid Micro Biosystems currently has a consensus rating of “Moderate Buy” and an average target price of $8.00.

Rapid Micro Biosystems Stock Down 5.2%

Shares of NASDAQ:RPID opened at $2.75 on Friday. The stock has a market capitalization of $121.88 million, a P/E ratio of -2.72 and a beta of 1.33. The stock’s 50-day moving average price is $3.52 and its 200-day moving average price is $3.32. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42. Rapid Micro Biosystems has a 12-month low of $0.87 and a 12-month high of $4.50.

Rapid Micro Biosystems (NASDAQ:RPID) last released its earnings results on Friday, November 7th. The company reported ($0.26) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.26). The company had revenue of $7.84 million during the quarter, compared to analyst estimates of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. On average, equities analysts anticipate that Rapid Micro Biosystems will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Rapid Micro Biosystems

A number of large investors have recently modified their holdings of RPID. Geode Capital Management LLC lifted its holdings in Rapid Micro Biosystems by 1.6% in the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock worth $704,000 after buying an additional 3,143 shares during the period. American Century Companies Inc. raised its position in shares of Rapid Micro Biosystems by 46.1% in the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after acquiring an additional 5,341 shares in the last quarter. Susquehanna International Group LLP lifted its stake in shares of Rapid Micro Biosystems by 12.6% in the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after purchasing an additional 6,528 shares during the period. Hudson Bay Capital Management LP purchased a new position in shares of Rapid Micro Biosystems in the 3rd quarter valued at approximately $38,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after purchasing an additional 15,255 shares in the last quarter. Institutional investors own 52.60% of the company’s stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.